NDMA OTC labeling "feedback" request
This article was originally published in The Tan Sheet
Executive Summary
Denied, FDA tells the trade association in a June 10 letter. "We are aware of your concerns and previously met on May 8, 1997, June 27, 1997, July 14, 1997 (NDAC meeting), and Sept. 30, 1997 to discuss NDMA's concerns and views on various OTC labeling issues. In addition, we extended the comment period for the proposed rule until Oct. 6, 1997, to allow NDMA and others additional time to adequately address the proposed rule," FDA says. "We do not need further clarification of your views and, thus, we do not consider another meeting necessary at this time." NDMA had wanted to discuss modifying the proposed labeling format and a package size exemption further. FDA published the proposed rule Feb. 27, 1997 ("The Tan Sheet" March 3, 1997, pp. 1-9). FDA also denies the same request from CTFA...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning